ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

EYE // National Vision Holdings Inc.

DES <GO> NASDAQ RQD COCKPIT → CIK 0001710155 ↗
Health Care • Ophthalmic Goods
$16.64 ▲ +1.18 (+7.63%)
MKT CAP: $1.32B • VOL: 2.48M
EYE // ROARABLE RATING & 5-PILLAR RQD CONFIDENCE 02:00 EST DETERMINISTIC ENGINE
PRIOR: RQD 68/100 [C+] (+0 PT) • UNCHANGED
ROARABLE C+
RQD CONFIDENCE
68 / 100 +0D
5 X 20-PT QUANT PILLARS
E 0 D 35 C 59 B 70 A 86+
Roarable Hold — Upper Neutral / Watch for Breakout
01 MASSIVE / SEC XBRL
Forensic Fundamentals
[LOCKED] FLAGGED
UNLOCK BELOW TO REVEAL
02 INSTITUTIONAL TAPE & TREND
Whale & Options Flow
15 / 20
SOLID
52W RANGE 87% • VS 200D +8.8% • RSI 78.7
03 SEC XBRL CAPITAL ALLOCATION
Insider & Capital Conviction
[LOCKED] FLAGGED
UNLOCK BELOW TO REVEAL
04 FRED 90D r-MATRIX
Macro Regime Fit
16 / 20
STRONG
TAILWIND • r(10Y)=+0.00 (+23bp) • r(OAS)=+0.00
05 10-K REDLINE AUDIT
Forensic 10-K Risk
15 / 20
SOLID
20 BASE - 5 DEDUCT • 0 CRIT / 0 MED • STABLE
ALERT

Why did EYE's Forensic Fundamentals & Insider & Capital Conviction sub-score just flash a warning? Enter your email to unlock the full 5-Pillar Rating Breakdown + get instant alerts whenever EYE is Upgraded or Downgraded.

EYE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -28.34%📐 HORIZONTAL RANGE
2026-10-30O $16.95H $16.96L $16.22C $16.64VOL 2.42M
RES: $23.89SUP: $14.92SMA50: $17.04SMA200: $21.34
$26.92$23.62$20.32$17.02$13.73RES $23.89SUP $14.92$16.642026-04-302026-06-152026-07-312026-09-162026-10-30
EYE // INSTITUTIONAL BULL VS. BEAR FORENSIC DEBATE
UNDERWEIGHT CONVICTION: 43/100
BEAR 0
100 BULL

National Vision Holdings Inc. (EYE) exhibits 45.0% gross margins and 4.4% return on invested capital within Health Care (Ophthalmic Goods), balanced against a 12.4x enterprise multiple and 4.8% implied options volatility.

▲ INSTITUTIONAL BULL THESIS (LONG)
01. Operating Leverage & Capital Efficiency Moat

Sustained 45.0% gross profitability converts into 3.0% operating margin and 4.4% ROIC, outpacing sector cost of capital.

ROIC: 4.4% // GM: 45.0%
02. Top-Line Expansion & Cash Conversion

YoY revenue trajectory of +9.0% paired with 5.58% free cash flow yield supports self-funded R&D and capital return.

REV YOY: +9.0% // FCF YLD: 5.58%
03. Balance Sheet Solvency & Forensic Quality

Altman Z-Score of 3.80 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.

ALTMAN Z: 3.80 // F-SCORE: 7/9
▼ INSTITUTIONAL BEAR THESIS (SHORT / RISK)
01. Multiple Compression & Duration Sensitivity

Trading at 44.4x trailing P/E (41.3x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.

P/E: 44.4x // EV/EBITDA: 12.4x
02. Options Skew & Event Volatility Risk

Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $16.64 max pain.

IMPL MOVE: ±5.2% // P/C: 0.85
03. Competitive Margin & CapEx Cycle Pressure

Elevated industry capital intensity and customer concentration in Ophthalmic Goods require continuous execution to defend 1.5% net margins.

NET MARGIN: 1.5% // D/E: 0.26x
KEY CATALYST // Upcoming 10-Q/10-K XBRL margin progression, guidance revision vs 41.3x forward consensus, and institutional 13F positioning.
MACRO REGIME // Monitor US 10Y Real Yields (DFII10) and High-Yield Credit Spreads (OAS) for beta-adjusted multiple impact (Beta 1.10).
FORM 4 & 13F FLOW OPEN OWN <GO>
FILER SIDE $ VALUE
INSPECT FULL OWNERSHIP LEDGER IN OWN <GO>
UNUSUAL OPTIONS TAPE OPEN OPT <GO>
STRIKE / EXP TYPE PREMIUM
INSPECT GEX & CHAIN IN OPT <GO>
KEY VALUATION & PROFITABILITY RATIOS XBRL FA <GO>
TRAILING P/E 44.4x
FORWARD P/E 41.3x
EV / EBITDA 12.4x
FCF YIELD 5.58%
GROSS MARGIN —
OPERATING MARGIN 3.0%
NET MARGIN 1.5%
ROIC % 4.4%
REV GROWTH YOY +9.0%
DILUTED EPS TTM $0.37
DEBT / EQUITY 0.26x
DIVIDEND YIELD 0.00%
RSI-14 MOMENTUM 45.6
5Y EQUITY BETA —
FRED MACRO SENSITIVITY (PEARSON r) ECST <GO>
MACRO CORRELATION CALIBRATION ACTIVE BELOW.
FRED MACRO REGIME STRESS-TEST SIMULATOR // EYEPEARSON R VARIANCE ENGINE
01 // SELECT FEDERAL RESERVE & CREDIT SHOCK SCENARIO
02 // POSITION NOTIONAL EXPOSURE
HEADLINE STRESS SCORE
75/100SEVERE DRAWDOWN PRESSURE
PRIMARY FACTOR EXPOSURE
DFII10 // -0.61 r
Latest: 2.08%
EST. DIRECTIONAL MOVE
-8.50%
Implied Px: $15.23
EST. DOLLAR VARIANCE
-$4,248
On $50,000 Notional
[LOCKED // MULTI-FACTOR DRAWDOWN HEDGE & MACRO TRIGGER ALERT]

Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for EYE & activate live FRED threshold breach alerts.

HEAD-TO-HEAD PEER COMPARISONS COMP <GO>